Sector consensus Monte Rosa Therapeutics, Inc.
Stocks
GLUE
US61225M1027
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.88 USD | +1.08% |
|
-29.98% | +1.28% |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 29.5 | +87.78% | 6 | ||||||
| 680.7 | +20.14% | 23 | ||||||
| 213.66 | +8.01% | 21 | ||||||
| 275.17 | +18.39% | 18 | ||||||
| 429.34 | +30.18% | 25 | ||||||
| 264,708.89 | +35.75% | 24 | ||||||
| 267.65 | +23.26% | 18 | ||||||
| 581.83 | -0.54% | 12 | ||||||
| 72.53 | +3.79% | 14 | ||||||
| 267.71 | +0.83% | 14 | ||||||
| 185.56 | +15.13% | 16 | ||||||
| 69.73 | -3.02% | 11 | ||||||
| 138.56 | +25.74% | 6 | ||||||
| 636.33 | +71.91% | 18 | ||||||
| 130.53 | -2.95% | 12 | ||||||
| 37.73 | -4.72% | 11 | ||||||
| 150.54 | +2.98% | 13 | ||||||
| 89.33 | +63.94% | 21 | ||||||
| 131 | +23.11% | 22 | ||||||
| 44.64 | +6.98% | 14 | ||||||
| Average | 13,457.05 | +21.33% | 16 | ||||||
| Weighted average by Cap. | 23,441.86 | +18.93% | 19 |
- Stock Market
- Stocks
- GLUE Stock
- Sector Monte Rosa Therapeutics, Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
